SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __ )*
BIONX IMPLANTS, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
09064Q106
- --------------------------------------------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP NO. 09064Q106
- --------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only): Terence D. Wall
- --------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) (b)
- --------------------------------------------------------------------------------
(3) SEC Use Only
- --------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: United States
- --------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each (5) Sole Voting
Reporting Person With Power: 2,568,717*
(6) Shared Voting
Power: --
(7) Sole Dispositive
Power: 2,568,717*
(8) Shared Dispositive
Power: --
- --------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person: 2,568,717*
- --------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
- --------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 28.8%*
- --------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): IN
- --------------------------------------------------------------------------------
* Mr. Terence D. Wall beneficially owns 2,568,717 shares of Bionx Implants, Inc.
common stock ("Common Stock"). All of Mr. Wall's shares of Common Stock are held
in an investment partnership which he controls. 484,421 of such shares of Common
Stock represent Mr. Wall's proportionate equity interest in 2,684,211 shares of
Common Stock owned by Bionix, B.V., a Dutch company. Pursuant to an agreement
with Bionix, B.V., Mr. Wall has the right to cause Bionix, B.V. to transfer to
him such 484,421 shares.
Item 1(a). Name of Issuer: Bionx Implants, Inc.
- --------------------------------------------------------------------------------
Item 1(b). Address of Issuer's Principal Executive Offices: 1777 Sentry Parkway
West, Gwynedd Hall, Suite 400, Blue Bell, Pennsylvania 19422
- --------------------------------------------------------------------------------
Item 2(a). Name of Person Filing: Terence D. Wall
- --------------------------------------------------------------------------------
Item 2(b). Address of Principal Business Office or, if none, Residence: 20
Campus Road, Totowa, New Jersey 07512
- --------------------------------------------------------------------------------
Item 2(c). Citizenship: United States
- --------------------------------------------------------------------------------
Item 2(d). Title of Class of Securities: Common Stock
- --------------------------------------------------------------------------------
Item 2(e). CUSIP No.: 09064Q106
- --------------------------------------------------------------------------------
Item 3. If This Statement Is Filed Pursuant to Rules 13d-1(b), or 13d-2(b),
check whether the Person Filing is a
(a) [ ] Broker or Dealer registered under Section 15 of the Act.
(b) [ ] Bank as defined in section 3(a)(6) of the Act.
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act.
(d) [ ] Investment Company registered under section 8 of the Investment
Company Act.
(e) [ ] Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940.
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of 1974 or Endowment
fund; see Rule 13d-1(b)(1)(ii)(H).
(g) [ ] Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G)
(Note: See Item 7).
(h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H).
Item 4. Ownership
(a) Amount Beneficially Owned (as of December 31, 1997):
2,568,717*
(b) Percent of Class (as of December 31, 1997):
28.8%*
(c) Number of Shares as to which such person has:
(i) sole power to vote or to direct the vote 2,568,717*
(ii) shared power to vote or to direct the vote --
----------
(iii) sole power to dispose or to direct the disposition of
2,568,717*
(iv) shared power to dispose or to direct the disposition of --
----------
* Mr. Terence D. Wall beneficially owns 2,568,717 shares of Bionx Implants, Inc.
common stock ("Common Stock"). All of Mr. Wall's shares of Common Stock are held
in an investment partnership which he controls. 484,421 of such shares of Common
Stock represent Mr. Wall's proportionate equity interest in 2,684,211 shares of
Common Stock owned by Bionix, B.V., a Dutch company. Pursuant to an agreement
with Bionix, B.V., Mr. Wall has the right to cause Bionix, B.V. to transfer to
him such 484,421 shares.
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ ].
Item 6. Ownership of More Than Five Percent on Behalf of Another Person. N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company. N/A
Item 8. Identification and Classification of Members of the Group. N/A
Item 9. Notice of Dissolution of Group. N/A
Item 10. Certification. N/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 6, 1998
(Date)
/s/ Michael E. Grossman
(Signature)
Michael E. Grossman, Attorney-in-Fact
(Name/Title)
Attention: Intentional misstatements or omissions of fact
constitute Federal criminal violations (See 18 U.S.C. 1001).
